Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Broich

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
The Journal of Prevention of Alzheimer'S Disease|March 28, 2017
PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's DiseaseH Hampel, S E O'Bryant, J I Castrillo, et al.
The American Journal of Psychiatry|February 1, 1996
[123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neurolepticsE Klemm, F Grünwald, S Kasper, et al.
Progress in Neurobiology|December 7, 2010
Biomarkers for Alzheimer's disease therapeutic trialsHarald Hampel, Gordon Wilcock, Sandrine Andrieu, et al.
The Journal of Prevention of Alzheimer'S Disease|October 20, 2015
The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target PopulationsE Cavedo, S Lista, Z Khachaturian, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
The Journal of Prevention of Alzheimer'S Disease|March 28, 2017
PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's DiseaseH Hampel, S E O'Bryant, J I Castrillo, et al.
The American Journal of Psychiatry|February 1, 1996
[123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neurolepticsE Klemm, F Grünwald, S Kasper, et al.
Progress in Neurobiology|December 7, 2010
Biomarkers for Alzheimer's disease therapeutic trialsHarald Hampel, Gordon Wilcock, Sandrine Andrieu, et al.
The Journal of Prevention of Alzheimer'S Disease|October 20, 2015
The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target PopulationsE Cavedo, S Lista, Z Khachaturian, et al.
Pageof 5